DLB
Dolby Laboratories, Inc.
$49.15
+0.64 (+1.32%)
At close · Jul 15
Market Cap
$4.73B
Shares
94,598,115
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-04-30 | 2026-03-27 | |
| 8-K | 2026-04-30 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-02-06 | 2026-02-03 | |
| 8-K | 2026-01-29 | — | |
| 10-Q | 2026-01-29 | 2025-12-26 | |
| DEF 14A | 2025-12-16 | 2026-02-03 | |
| 8-K | 2025-11-18 | — | |
| 10-K | 2025-11-18 | 2025-09-26 | |
| 8-K | 2025-11-14 | 2025-11-11 | |
| 10-Q | 2025-07-31 | 2025-06-27 | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-05-01 | 2025-03-28 | |
| 8-K | 2025-05-01 | — | |
| 8-K | 2025-02-07 | 2025-02-04 | |
| 10-Q | 2025-01-30 | 2024-12-27 | |
| 8-K | 2025-01-29 | — | |
| DEF 14A | 2024-12-20 | 2025-02-04 | |
| 10-K | 2024-11-19 | 2024-09-27 | |
| 8-K | 2024-11-19 | 2024-11-14 | |
| 8-K | 2024-11-15 | 2024-11-12 | |
| 8-K | 2024-08-19 | — | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-28 | |
| 8-K | 2024-06-06 | — | |
| 10-Q | 2024-05-02 | 2024-03-29 | |
| 8-K | 2024-05-02 | — | |
| 8-K | 2024-02-09 | 2024-02-06 | |
| 10-Q | 2024-02-02 | 2023-12-29 | |
| 8-K | 2024-02-01 | — | |
| DEF 14A | 2023-12-22 | 2024-02-06 | |
| 10-K | 2023-11-17 | 2023-09-29 | |
| 8-K | 2023-11-16 | 2023-11-14 | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 10-Q | 2023-05-05 | 2023-03-31 | |
| 8-K | 2023-05-04 | — | |
| 8-K | 2023-02-10 | 2023-02-07 | |
| 8-K | 2023-02-02 | — | |
| 10-Q | 2023-02-02 | 2022-12-30 | |
| DEF 14A | 2022-12-19 | 2023-02-07 | |
| 8-K | 2022-11-18 | 2022-11-16 | |
| 10-K | 2022-11-18 | 2022-09-30 | |
| 8-K | 2022-11-17 | — | |
| 10-Q | 2022-08-09 | 2022-07-01 | |
| 8-K | 2022-08-09 | — | |
| 8-K | 2022-05-05 | — | |
| 10-Q | 2022-05-05 | 2022-04-01 | |
| 8-K | 2022-02-11 | 2022-02-08 | |
| 10-Q | 2022-02-04 | 2021-12-31 |
Showing 1–50 of 77 filings
Key facts
CIK
1308547
CUSIP
25659T107
13F (30d)
35 filings
34 filers
Visit website
Investor relations